| 000 | 00994 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513133741.0 | ||
| 264 | 0 | _c19980204 | |
| 008 | 199802s 0 0 eng d | ||
| 022 | _a0090-8258 | ||
| 024 | 7 |
_a10.1006/gyno.1997.4896 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Reilly, S | |
| 245 | 0 | 0 |
_aLife-threatening myelosuppression in patients with occult renal impairment receiving topotecan. _h[electronic resource] |
| 260 |
_bGynecologic oncology _cDec 1997 |
||
| 300 |
_a329-30 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Diseases _xcomplications |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xcomplications |
| 650 | 0 | 4 |
_aTopotecan _xadverse effects |
| 700 | 1 | _aArmstrong, D K | |
| 700 | 1 | _aGrochow, L B | |
| 773 | 0 |
_tGynecologic oncology _gvol. 67 _gno. 3 _gp. 329-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/gyno.1997.4896 _zAvailable from publisher's website |
| 999 |
_c9411074 _d9411074 |
||